AstraZeneca (AZN) leads Zacks Research highlights with strong drug growth and pipeline momentum, while HSBC and Disney navigate costs and competition.
The US Food and Drug Administration approved the first generics of UK pharma major AstraZeneca’s Farxiga (dapagliflozin) ...
The funding round, led by Novartis and OrbiMed, will allow Sidewinder to progress two of its bispecific ADC programmes to ...
As a researcher studying the politics of health care, I believe it’s helpful to look to countries that have successfully ...
Alembic Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration (USFDA) for ...
Walton Isaacson has named Maria Robles vice president of business development, leading new business strategy.
Robot adoption is advancing rapidly, driven by declining costs, rising demand, and the integration of artificial intelligence ...
ImmuPharma PLC (AIM:IMM, FRA:25I), the specialist drug discovery and development company, says it is actively progressing ...
Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development of commercialization of innovative cardiovascular medicines, today announced that management will ...
GoodRx reports on how to handle situations when medications aren't covered by insurance, offering tips for appeals, ...
The Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund (ETO) offers a 7.63% yield, primarily through a portfolio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results